TX
Texas House Bill HB2880

Texas 2015 - 84th Regular

Texas House Bill HB2880 Compare Versions

Only one version of the bill is available at this time.
OldNewDifferences
11 84R10902 GCB-D
22 By: Price H.B. No. 2880
33
44
55 A BILL TO BE ENTITLED
66 AN ACT
77 relating to the placement of certain substances in Penalty Groups 2
88 and 2-A of the Texas Controlled Substances Act for the purpose of
99 prosecution of criminal offenses involving those substances.
1010 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
1111 SECTION 1. Section 481.103(a), Health and Safety Code, is
1212 amended to read as follows:
1313 (a) Penalty Group 2 consists of:
1414 (1) any quantity of the following hallucinogenic
1515 substances, their salts, isomers, and salts of isomers, unless
1616 specifically excepted, if the existence of these salts, isomers,
1717 and salts of isomers is possible within the specific chemical
1818 designation:
1919 alpha-ethyltryptamine;
2020 alpha-methyltryptamine;
2121 5-methoxy-alpha-methyltryptamine;
2222 (2-aminopropyl) Benzofuran (trade or other name:
2323 APB);
2424 (2-aminopropyl) Dihydrobenzofuran (trade or other
2525 name: APDB);
2626 4-bromo-2, 5-dimethoxyamphetamine (some trade or
2727 other names: 4-bromo-2, 5-dimethoxy-alpha-methylphenethylamine;
2828 4-bromo-2, 5-DMA);
2929 4-bromo-2, 5-dimethoxyphenethylamine;
3030 Bufotenine (some trade and other names: 3-(beta-
3131 Dimethylaminoethyl)-5-hydroxyindole; 3-(2-dimethylaminoethyl)- 5-
3232 indolol; N, N-dimethylserotonin; 5-hydroxy-N, N-
3333 dimethyltryptamine; mappine);
3434 [3-(3-Carbamoylphenyl)phenyl]N-cyclohexyl
3535 Carbamate (trade or other name: URB-597);
3636 Diethyltryptamine (some trade and other
3737 names: N, N-Diethyltryptamine, DET);
3838 2, 5-dimethoxyamphetamine (some trade or other
3939 names: 2, 5-dimethoxy-alpha-methylphenethylamine; 2, 5-DMA);
4040 2, 5-dimethoxy-4-ethylamphetamine (trade or other
4141 name: DOET);
4242 2, 5-dimethoxy-4-(n)-propylthiophenethylamine
4343 (trade or other name: 2C-T-7);
4444 Dimethyltryptamine (trade or other name: DMT);
4545 Dronabinol (synthetic) in sesame oil and
4646 encapsulated in a soft gelatin capsule in a U.S. Food and Drug
4747 Administration approved drug product (some trade or other names for
4848 Dronabinol: (a6aR-trans)-6a,7,8,10a-tetrahydro- 6,6, 9-
4949 trimethyl-3-pentyl-6H- dibenzo [b,d]pyran-1-ol or (-)-delta-9-
5050 (trans)- tetrahydrocannabinol);
5151 Ethylamine Analog of Phencyclidine (some trade or
5252 other names: N-ethyl-1-phenylcyclohexylamine, (1-
5353 phenylcyclohexyl) ethylamine, N-(1-phenylcyclohexyl) ethylamine,
5454 cyclohexamine, PCE);
5555 Fentanyl mimetic substances structurally derived
5656 from fentanyl by substitution in the phenethyl group, substitution
5757 in the piperidine ring, substitution in the aniline ring,
5858 replacement of the phenyl portion of the phenethyl group,
5959 replacement of the N-Propionyl group, or any combination of those
6060 substitutions or replacements;
6161 Hydroxyphencyclidine (trade or other name:
6262 HO-PCP);
6363 Ibogaine (some trade or other names: 7-Ethyl-6,
6464 6, beta 7, 8, 9, 10, 12, 13-octahydro-2-methoxy-6, 9-methano-5H-
6565 pyrido [1', 2':1, 2] azepino [5, 4-b] indole; tabernanthe iboga.);
6666 Mescaline;
6767 5-methoxy-N, N-diisopropyltryptamine;
6868 5-methoxy-3, 4-methylenedioxy amphetamine;
6969 4-methoxyamphetamine (some trade or other
7070 names: 4-methoxy-alpha-methylphenethylamine;
7171 paramethoxyamphetamine; PMA);
7272 1-methyl- 4-phenyl-4-propionoxypiperidine (MPPP,
7373 PPMP);
7474 4-methyl-2, 5-dimethoxyamphetamine (some trade
7575 and other names: 4-methyl-2, 5-dimethoxy-alpha-
7676 methylphenethylamine; "DOM"; "STP");
7777 3,4-methylenedioxy methamphetamine (MDMA, MDM);
7878 3,4-methylenedioxy amphetamine;
7979 3,4-methylenedioxy N-ethylamphetamine (Also
8080 known as N-ethyl MDA);
8181 Nabilone (Another name for nabilone: (+)-trans-
8282 3-(1,1-dimethylheptyl)- 6,6a, 7,8,10,10a-hexahydro-1-hydroxy- 6,
8383 6-dimethyl-9H-dibenzo[b,d] pyran-9-one;
8484 N-benzylpiperazine (some trade or other
8585 names: BZP; 1-benzylpiperazine);
8686 N-ethyl-3-piperidyl benzilate;
8787 N-hydroxy-3,4-methylenedioxyamphetamine (Also
8888 known as N-hydroxy MDA);
8989 4-methylaminorex;
9090 N-methyl-3-piperidyl benzilate;
9191 N-methyltryptamine mimetic substances
9292 structurally derived from N-methyltryptamine by substitution at
9393 the nitrogen atom, substitution at the indole ring, substitution at
9494 the alpha carbon, substitution at the beta carbon, or any
9595 combination of those substitutions, excluding
9696 5-methoxy-N-Acetyltryptamine, and including, by example:
9797 ACO-DMT;
9898 Baeocystine;
9999 BROMO-DALT;
100100 DIPT;
101101 DMT;
102102 DPT;
103103 HO-DET;
104104 HO-DIPT;
105105 HO-DMT;
106106 HO-DPT;
107107 HO-MET;
108108 MEO-DALT;
109109 MEO-DET;
110110 MEO-DIPT;
111111 MEO-DPT;
112112 MEO-NMT;
113113 MET;
114114 NMT; and
115115 Norbufotenin;
116116 Parahexyl (some trade or other names: 3-Hexyl-1-
117117 hydroxy-7, 8, 9, 10-tetrahydro-6, 6, 9-trimethyl-6H-dibenzo [b, d]
118118 pyran; Synhexyl);
119119 Phencyclidine mimetic substances structurally
120120 derived from phenylcyclohexylpiperidine by substitution at the
121121 phenyl ring, substitution at the piperidine ring, substitution at
122122 the cyclohexyl ring, replacement of the phenyl ring, or any
123123 combination of those substitutions or replacements, including, by
124124 example, compounds such as:
125125 Amino-PCP;
126126 BCP;
127127 Bromo-PCP;
128128 BTCP;
129129 Chloro-PCP;
130130 Fluoro-PCP;
131131 HO-PCP;
132132 MEO-PCP;
133133 Methyl-PCP;
134134 Nitro-PCP;
135135 OXO-PCP;
136136 PCE;
137137 PCM;
138138 PCPY;
139139 TCP; and
140140 TCPY;
141141 1-Phenylcyclohexylamine;
142142 1-Piperidinocyclohexanecarbonitrile (PCC);
143143 Psilacetin;
144144 Psilocin;
145145 Psilocybin;
146146 Pyrrolidine Analog of Phencyclidine (some trade
147147 or other names: 1-(1-phenylcyclohexyl)-pyrrolidine, PCPy, PHP);
148148 Tetrahydrocannabinols, other than marihuana, and
149149 synthetic equivalents of the substances contained in the plant, or
150150 in the resinous extractives of Cannabis, or synthetic substances,
151151 derivatives, and their isomers with similar chemical structure and
152152 pharmacological activity such as:
153153 delta-1 cis or trans tetrahydrocannabinol,
154154 and their optical isomers;
155155 delta-6 cis or trans tetrahydrocannabinol,
156156 and their optical isomers;
157157 delta-3, 4 cis or trans
158158 tetrahydrocannabinol, and its optical isomers; and
159159 compounds of these structures, regardless of
160160 numerical designation of atomic positions, since nomenclature of
161161 these substances is not internationally standardized;
162162 Thiophene Analog of Phencyclidine (some trade or
163163 other names: 1-[1-(2-thienyl) cyclohexyl] piperidine; 2-Thienyl
164164 Analog of Phencyclidine; TPCP, TCP);
165165 1-pyrrolidine (some trade or other name: TCPy);
166166 1-(3-trifluoromethylphenyl)piperazine (trade or
167167 other name: TFMPP); and
168168 3,4,5-trimethoxy amphetamine;
169169 (2) Phenylacetone (some trade or other
170170 names: Phenyl-2-propanone; P2P, Benzymethyl ketone, methyl benzyl
171171 ketone);
172172 (3) unless specifically excepted or unless listed in
173173 another Penalty Group, a material, compound, mixture, or
174174 preparation that contains any quantity of the following substances
175175 having a potential for abuse associated with a depressant or
176176 stimulant effect on the central nervous system:
177177 Aminoindane mimetic substances structurally
178178 derived from Aminoindane by substitution at the nitrogen atom,
179179 substitution at the indane ring, replacement of the amino group
180180 with another N group or any carbon, or any combination of those
181181 substitutions or replacements, including, by example, compounds
182182 such as:
183183 AMMI;
184184 IAI;
185185 MDAI; and
186186 MMAI;
187187 Aminorex (some trade or other
188188 names: aminoxaphen; 2-amino-5-phenyl-2-oxazoline; 4,5-dihydro-5-
189189 phenyl-2-oxazolamine);
190190 Amphetamine, its salts, optical isomers, and
191191 salts of optical isomers;
192192 Cathinone (some trade or other names: 2-amino-1-
193193 phenyl-1-propanone, alpha-aminopropiophenone, 2-
194194 aminopropiophenone);
195195 Etorphine Hydrochloride;
196196 Fenethylline and its salts;
197197 Fluoroamphetamine;
198198 Fluoromethamphetamine;
199199 Lisdexamfetamine, including its salts, isomers,
200200 and salts of isomers;
201201 Mecloqualone and its salts;
202202 Methaqualone and its salts;
203203 Methcathinone (some trade or other names: 2-
204204 methylamino-propiophenone; alpha- (methylamino)propiophenone
205205 [alpha-(methylamino)propriophenone];
206206 2-(methylamino)-1-phenylpropan-1-one;
207207 alpha-N-methylaminopropiophenone [alpha-N-
208208 methylaminopropriophenone]; monomethylpropion; ephedrone, N-
209209 methylcathinone; methylcathinone; AL-464; AL-422; AL-463; and UR
210210 1431);
211211 Methiopropamine;
212212 2-(Methoxyphenyl)-2-
213213 (ethylamino)cyclohexanone(methoxetamine);
214214 2-(Methoxyphenyl)-2-
215215 (methylamino)cyclohexanone(methoxyketamine);
216216 Methoxyphencyclidine (trade or other name:
217217 MEO-PCP);
218218 Alpha-Pyrrolidinovalerothiophenone (trade or
219219 other name: alpha-PVT);
220220 N-Ethylamphetamine, its salts, optical isomers,
221221 and salts of optical isomers; and
222222 N,N-dimethylamphetamine (some trade or other
223223 names: N,N,alpha-trimethylbenzeneethaneamine;
224224 N,N,alpha-trimethylphenethylamine), its salts, optical isomers,
225225 and salts of optical isomers; and
226226 (4) any compound structurally derived from
227227 2-aminopropanal by substitution at the 1-position with any
228228 monocyclic or fused-polycyclic ring system, including:
229229 (A) compounds further modified by:
230230 (i) substitution in the ring system to any
231231 extent (including alkyl, alkoxy, alkylenedioxy, haloalkyl, or
232232 halide substituents), whether or not further substituted in the
233233 ring system by other substituents;
234234 (ii) substitution at the 3-position with an
235235 alkyl substituent; or
236236 (iii) substitution at the 2-amino nitrogen
237237 atom with alkyl or dialkyl groups, or inclusion of the 2-amino
238238 nitrogen atom in a cyclic structure; and
239239 (B) by example, compounds such as:
240240 4-Methylmethcathinone (Also known as
241241 Mephedrone);
242242 3,4-Dimethylmethcathinone (Also known as
243243 3,4-DMMC);
244244 3-Fluoromethcathinone (Also known as 3-FMC);
245245 4-Fluoromethcathinone (Also known as
246246 Flephedrone);
247247 3,4-Methylenedioxy-N-methylcathinone (Also
248248 known as Methylone);
249249 3,4-Methylenedioxypyrovalerone (Also known
250250 as MDPV);
251251 alpha-Pyrrolidinopentiophenone (Also known as
252252 alpha-PVP);
253253 Naphthylpyrovalerone (Also known as
254254 Naphyrone);
255255 beta-Keto-N-methylbenzodioxolylpropylamine
256256 (Also known as Butylone);
257257 beta-Keto-N-methylbenzodioxolylpentanamine
258258 (Also known as Pentylone);
259259 beta-Keto-Ethylbenzodioxolylbutanamine
260260 (Also known as Eutylone); and
261261 3,4-methylenedioxy-N-ethylcathinone (Also
262262 known as Ethylone).
263263 SECTION 2. Section 481.1031, Health and Safety Code, is
264264 amended to read as follows:
265265 Sec. 481.1031. PENALTY GROUP 2-A. Penalty Group 2-A
266266 consists of any quantity of a synthetic chemical compound that is a
267267 cannabinoid receptor agonist and mimics the pharmacological effect
268268 of naturally occurring cannabinoids, including:
269269 naphthoylindoles structurally derived from
270270 3-(1-naphthoyl)indole by substitution at the nitrogen atom of the
271271 indole ring by alkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,
272272 or 2-(4-morpholinyl)ethyl, whether or not further substituted in
273273 the indole ring to any extent, whether or not substituted in the
274274 napthyl ring to any extent, including:
275275 AM-2201;
276276 JWH-004;
277277 JWH-007;
278278 JWH-009;
279279 JWH-015;
280280 JWH-016;
281281 JWH-018;
282282 JWH-019;
283283 JWH-020;
284284 JWH-046;
285285 JWH-047;
286286 JWH-048;
287287 JWH-049;
288288 JWH-050;
289289 JWH-073;
290290 JWH-076;
291291 JWH-079;
292292 JWH-080;
293293 JWH-081;
294294 JWH-082;
295295 JWH-083;
296296 JWH-093;
297297 JWH-094;
298298 JWH-095;
299299 JWH-096;
300300 JWH-097;
301301 JWH-098;
302302 JWH-099;
303303 JWH-100;
304304 JWH-116;
305305 JWH-122;
306306 JWH-148;
307307 JWH-149;
308308 JWH-153;
309309 JWH-159;
310310 JWH-164;
311311 JWH-165;
312312 JWH-166;
313313 JWH-180;
314314 JWH-181;
315315 JWH-182;
316316 JWH-189;
317317 JWH-193;
318318 JWH-198;
319319 JWH-200;
320320 JWH-210;
321321 JWH-211;
322322 JWH-212;
323323 JWH-213;
324324 JWH-234;
325325 JWH-235;
326326 JWH-239;
327327 JWH-240;
328328 JWH-241;
329329 JWH-242;
330330 JWH-258;
331331 JWH-259;
332332 JWH-260;
333333 JWH-262;
334334 JWH-267;
335335 JWH-386;
336336 JWH-387;
337337 JWH-394;
338338 JWH-395;
339339 JWH-397;
340340 JWH-398;
341341 JWH-399;
342342 JWH-400;
343343 JWH-412;
344344 JWH-413; and
345345 JWH-414;
346346 naphthylmethylindones structurally derived from
347347 1H-indol-3-yl-(1-naphthyl)methane by substitution at the nitrogen
348348 atom of the indole ring by alkyl, alkenyl, cycloalkylmethyl,
349349 cycloalkylethyl, or 2-(4-morpholinyl)ethyl, whether or not further
350350 substituted in the indole ring to any extent, whether or not
351351 substituted in the naphthyl ring to any extent, including:
352352 JWH-175;
353353 JWH-184;
354354 JWH-185;
355355 JWH-192;
356356 JWH-194;
357357 JWH-195;
358358 JWH-196;
359359 JWH-197; and
360360 JWH-199;
361361 naphthoylpyrroles structurally derived from
362362 3-(1-naphthoyl)pyrrole by substitution at the nitrogen atom of the
363363 pyrrole ring by alkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,
364364 or 2-(4-morpholinyl)ethyl, whether or not further substituted in
365365 the pyrrole ring to any extent, whether or not substituted in the
366366 naphthyl ring to any extent, including:
367367 JWH-030;
368368 JWH-145;
369369 JWH-146;
370370 JWH-147;
371371 JWH-150;
372372 JWH-156;
373373 JWH-243;
374374 JWH-244;
375375 JWH-245;
376376 JWH-246;
377377 JWH-292;
378378 JWH-293;
379379 JWH-307;
380380 JWH-308;
381381 JWH-309;
382382 JWH-346;
383383 JWH-347;
384384 JWH-348;
385385 JWH-363;
386386 JWH-364;
387387 JWH-365;
388388 JWH-366;
389389 JWH-367;
390390 JWH-368;
391391 JWH-369;
392392 JWH-370;
393393 JWH-371;
394394 JWH-372;
395395 JWH-373; and
396396 JWH-392;
397397 naphthylmethylindenes structurally derived from
398398 1-(1-naphthylmethyl)indene by substitution at the 3-position of
399399 the indene ring by alkyl, alkenyl, cycloalkylmethyl,
400400 cycloalkylethyl, or 2-(4-morpholinyl)ethyl, whether or not further
401401 substituted in the indene ring to any extent, whether or not
402402 substituted in the naphthyl ring to any extent, including:
403403 JWH-171;
404404 JWH-172;
405405 JWH-173; and
406406 JWH-176;
407407 phenylacetylindoles structurally derived from
408408 3-phenylacetylindole by substitution at the nitrogen atom of the
409409 indole ring with alkyl, alkenyl, cycloalkylmethyl,
410410 cycloalkylethyl, or 2-(4-morpholinyl)ethyl, whether or not further
411411 substituted in the indole ring to any extent, whether or not
412412 substituted in the phenyl ring to any extent, including:
413413 AM-694;
414414 AM-1241;
415415 JWH-167;
416416 JWH-203;
417417 JWH-204;
418418 JWH-205;
419419 JWH-206;
420420 JWH-208;
421421 JWH-237;
422422 JWH-248;
423423 JWH-249;
424424 JWH-250;
425425 JWH-251;
426426 JWH-252;
427427 JWH-253;
428428 JWH-302;
429429 JWH-303;
430430 JWH-305;
431431 JWH-306;
432432 JWH-311;
433433 JWH-312;
434434 JWH-313;
435435 JWH-314; and
436436 JWH-315;
437437 cyclohexylphenols structurally derived from
438438 2-(3-hydroxycyclohexyl)phenol by substitution at the 5-position of
439439 the phenolic ring by alkyl, alkenyl, cycloalkylmethyl,
440440 cycloalkylethyl, or 2-(4-morpholinyl)ethyl, whether or not
441441 substituted in the cyclohexyl ring to any extent, including:
442442 CP-55,940;
443443 CP-47,497;
444444 analogues of CP-47,497, including VII, V, VIII, I,
445445 II, III, IV, IX, X, XI, XII, XIII, XV, and XVI;
446446 JWH-337;
447447 JWH-344;
448448 JWH-345; and
449449 JWH-405; [and]
450450 cannabinol derivatives, except where contained in
451451 marihuana, including tetrahydro derivatives of cannabinol and
452452 3-alkyl homologues of cannabinol or of its tetrahydro derivatives,
453453 such as:
454454 Nabilone;
455455 HU-210;
456456 HU-211; and
457457 WIN-55,212-2;
458458 3-Adamantoylindole, with substitution at the
459459 nitrogen atom of the indole ring, whether or not further
460460 substituted in the indole ring to any extent or in the adamantyl
461461 ring to any extent, including, by example, compounds such as
462462 AB-001;
463463 Indazole-3-Carboxamide with substitution at the
464464 nitrogen atom of the indazole ring, whether or not further
465465 substituted in the indazole ring to any extent or in the adamantyl
466466 ring to any extent, including, by example, compounds such as:
467467 AB-Fubinaca;
468468 AB-Pinaca;
469469 AKB-48;
470470 Apinaca; and
471471 Fluoro-AKB-48;
472472 N-(adamantyl)-indole-3-Carboxamide, with
473473 substitution at the nitrogen atom of the indole ring, whether or not
474474 further substituted in the indole ring to any extent or in the
475475 adamantyl ring to any extent, including, by example, compounds such
476476 as SDB-001; and
477477 8-Quinolinyl-indole-3-carboxylate with
478478 substitution at the nitrogen atom of the indole ring, whether or not
479479 further substituted in the indole ring to any extent or in the
480480 quinoline ring to any extent, including, by example, compounds such
481481 as:
482482 Fluoro-PB-22; and
483483 PB-22.
484484 SECTION 3. The change in law made by this Act applies only
485485 to an offense committed on or after the effective date of this Act.
486486 An offense committed before the effective date of this Act is
487487 governed by the law in effect on the date the offense was committed,
488488 and the former law is continued in effect for that purpose. For
489489 purposes of this section, an offense was committed before the
490490 effective date of this Act if any element of the offense occurred
491491 before that date.
492492 SECTION 4. This Act takes effect September 1, 2015.